| Dr Jennifer Drew Ortega, PHARMD | |
|
1223 Clearview Dr, Lansing, KS 66043-5211 | |
| (785) 218-6274 | |
| Not Available |
| Full Name | Dr Jennifer Drew Ortega |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1223 Clearview Dr, Lansing, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992013387 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-13410 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer Drew Ortega, PHARMD 1223 Clearview Dr, Lansing, KS 66043-5211 Ph: (785) 218-6274 | Dr Jennifer Drew Ortega, PHARMD 1223 Clearview Dr, Lansing, KS 66043-5211 Ph: (785) 218-6274 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, has completed the previously announced sales of its two laboratory-testing services businesses, Athena Diagnostics and Lancaster Laboratories, in two separate transactions, resulting in total proceeds of $940 million.
Researchers with the University of Florida and the California Institute of Technology have developed a new strain of genetically modified mice that allow scientists to examine the potential usefulness of new therapies for Alzheimer's disease.
An experimental drug recently concluded a successful third-phase clinical trial and could potentially offer a new treatment for about 300,000 Canadians who have worsening chronic heart failure.
In this volume an international group of basic and clinical investigators presents their latest research on neuroendocrine physiology, advances in the control of the onset of puberty and its disorders, and basic and clinical aspects of the GH/IGF-1 and hypothalamic-pituitary-adrenal axes. An entire section is dedicated to pituitary tumors, including genetics and neuroimaging, and another covers the neuroendocrine control of substrate metabolism, including hypothalamic obesity and anorexia.
Children's exposure to alcohol advertising during early adolescence appears to influence both beer drinking and their intentions to drink a year later, according to a RAND Corporation study.
› Verified 7 days ago